Measles vaccines
Janaszek, W.
Przeglad Epidemiologiczny 53(3-4): 281-290
1999
ISSN/ISBN: 0033-2100 PMID: 10800565 Document Number: 504443
The World Health Organization has settled the goal of measles elimination in European Region by the year 2007. The proposed measles elimination strategy is to reduce an estimated proportion of susceptible individuals in the population to low levels by intensive vaccination and to maintain these low levels for some years. In this strategy, the quality of measles vaccine used for immunization is crucial. The different kinds of measles vaccines used at present in the world and novel generations of vaccines are presented.
Document emailed within 1 workday
Related Documents
Bennett, J.V.; Fernandez de Castro, J.; Valdespino-Gomez, J.Luis.; Garcia-Garcia, M.de.Lourdes.; Islas-Romero, R.; Echaniz-Aviles, G.; Jimenez-Corona, A.; Sepulveda-Amor, J. 2002: Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bulletin of the World Health Organization 80(10): 806-812Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Wegmann, A.; Glück, R.; Just, M.; Mischler, R.; Paroz, P.; Germanier, R. 1986: Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines Developments in Biological Standardization 65: 69-74
Stehr, K.; Enders-Ruckle, G.; Spiess, H. 1975: Measles vaccination with split vaccines and living vaccines Münchener Medizinische Wochenschrift 117(27): 1159-1164
Burke, E.C. 1991: Measles, immunizations, and vaccines Minnesota Medicine 74(8): 5
Pannuti, C.S.; de Souza, V.A.; Takaoka, N.; da Silva Leme, S.T.; Pereira, C.R.; de Souza Carvalho, R.P.; Amato Neto, V. 1987: Interference between measles and poliomyelitis vaccines Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 103(3): 227-232
Nasibov, M.N.; Yakovleva, N.V.; Smorodintsev, A.A. 1970: Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella Progress in Immunobiological Standardization 4: 676-682
Arya, S.C.; Agarwal, N. 2003: Adverse reaction potential of three measles-mumps-rubella combination vaccines Revista Panamericana de Salud Publica 13(4): 273-4; Author Reply 274
Dos Santos, B.A.ôn.; Ranieri, T.S.; Bercini, M.; Schermann, M.T.; Famer, S.; Mohrdieck, R.; Maraskin, T.; Wagner, M.ár.B. 2002: An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines Revista Panamericana de Salud Publica 12(4): 240-246
Adu, F.D.; Omotade, O.O.; Oyedele, O.I.; Ikusika, O.; Odemuyiwa, S.O.; Onoja, A.L. 1996: Field trial of combined yellow fever and measles vaccines among children in Nigeria East African Medical Journal 73(9): 579-582
Lerman, S.J.; Bollinger, M.; Brunken, J.M. 1981: Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination Pediatrics 68(1): 18-22
Villaseñor-Sierra, A.; Santos-Preciado, Jé.Ignacio.; Alvarez-y-Muñoz, Mía.Teresa.; Rivas-García, Mía.Elena.; Martínez-Sandoval, F.; Falcón-Franco, M.Antonio. 2005: Antibody development and frequency of events temporarily associated with measles and rubella vaccines among university health personnel in Jalisco Gaceta Medica de Mexico 141(6): 455-459
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Cassidy, W.M.; Jones, G.; Williams, K.; Deforest, A.; Forghani, B.; Virella, G.; Venters, C. 2005: Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 36(3): 187-192
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
2011: Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010 MMWR. Morbidity and mortality weekly report 60(12): 374-378
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Colomer Pache, M.; Arnedo Pena, A. 1988: Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination Medicina Clinica 91(17): 649-652
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. II. Socio-economic analysis Ugeskrift for Laeger 147(38): 3017-3022